AI-Twin is a cutting-edge technology that fuses engineered 3D multi-tissue constructs, derived from patient biopsies, with digital twins. These computational models simulate biological behavior, providing an advanced platform for personalized medicine, biomedical research, and clinical applications. AI-Twin stands at the forefront of healthcare innovation, accelerating the pathophysiological understanding and the development of individualized treatments.

先見基因科技 specializes in genetic testing that empowers individuals with detailed insights into their health risks and genetic predispositions. By leveraging state-of-the-art technology and a highly qualified research team, the company provides actionable health information, enabling personalized medical strategies. Their focus on high-throughput sequencing technology aids in delivering precise risk assessments for various diseases, ensuring that individuals can make informed health-related choices.